Chris Bailey

Chris Bailey

Development Director

Dr Bailey is responsible for delivering ImmBio’s development programmes.

Dr Bailey has extensive experience of vaccine development and scientific and regulatory management related to manufacturing, pre-clinical testing and clinical studies. He was previously responsible for all pre-clinical science (vaccines, rDNA products, gene therapies and small molecules) at Medeva and was a key member of the team responsible for the successful pan-European approval of Hepacare, a novel hepatitis B vaccine. He has also held senior scientific roles in a number of biotechnology and pharmaceutical companies.  Dr Bailey has a degree in Biochemistry from the University of Aberdeen and PhD from the University of Cambridge.

Contact Details:

Email: .(JavaScript must be enabled to view this email address)